SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001628280-22-023822
Filing Date
2022-08-29
Accepted
2022-08-29 15:16:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFC14A scheduledef14proxy2022.htm DEFC14A 361833
2 GRAPHIC proxycardinfoa04.jpg GRAPHIC 5043
  Complete submission text file 0001628280-22-023822.txt   371171
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filed by) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFC14A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Subject) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFC14A | Act: 34 | File No.: 001-11504 | Film No.: 221210865
SIC: 2836 Biological Products, (No Diagnostic Substances)